Beijing Beilu Pharmaceutical Co., Ltd. (SHE:300016)
China flag China · Delayed Price · Currency is CNY
8.93
-0.12 (-1.33%)
May 20, 2026, 2:25 PM CST

SHE:300016 Ratios and Metrics

Millions CNY. Fiscal year is Jan - Dec.
Fiscal Year
CurrentFY 2025FY 2024FY 2023FY 2022FY 2021
Period Ending
May '26 Dec '25 Dec '24 Dec '23 Jan '23 Jan '22
5,0944,4693,0503,5033,2084,523
Market Cap Growth
72.29%46.53%-12.92%9.20%-29.09%-4.32%
Enterprise Value
5,0284,4233,3883,6353,2394,391
Last Close Price
9.057.946.157.076.408.92
PE Ratio
39.2848.19223.42-284.2636.04
Forward PE
-19.2219.2219.2219.2219.22
PS Ratio
4.103.713.103.934.195.26
PB Ratio
2.071.851.671.961.672.17
P/TBV Ratio
2.412.172.092.301.982.71
P/FCF Ratio
1578.35-49.49-128.15-
P/OCF Ratio
21.8828.5518.7159.9125.1041.60
EV/Sales Ratio
4.053.673.454.084.235.11
EV/EBITDA Ratio
24.4524.2023.4664.5846.4123.08
EV/EBIT Ratio
46.2450.3463.64--34.43
EV/FCF Ratio
1557.97-54.97-129.42-
Debt / Equity Ratio
0.230.210.440.440.340.28
Debt / EBITDA Ratio
2.792.755.3713.308.923.02
Debt / FCF Ratio
178.06-12.94-25.84-
Net Debt / Equity Ratio
-0.09-0.070.100.02-0.06-0.15
Net Debt / EBITDA Ratio
-1.10-0.921.310.75-1.72-1.68
Net Debt / FCF Ratio
-69.942.713.07-0.49-4.798.18
Asset Turnover
0.370.380.340.320.270.30
Inventory Turnover
1.911.781.731.861.391.79
Quick Ratio
1.721.651.742.632.933.65
Current Ratio
2.392.402.573.333.894.57
Return on Equity (ROE)
5.64%4.17%0.01%-4.49%-0.23%5.54%
Return on Assets (ROA)
2.04%1.74%1.15%-0.55%-0.11%2.77%
Return on Invested Capital (ROIC)
3.99%3.36%2.77%-1.38%-0.29%6.87%
Return on Capital Employed (ROCE)
3.80%3.20%2.10%-1.00%-0.20%4.90%
Earnings Yield
2.42%2.08%0.45%-2.05%0.35%2.77%
FCF Yield
0.06%-1.39%2.02%-2.46%0.78%-0.86%
Dividend Yield
--0.81%-1.09%0.78%
Payout Ratio
31.34%40.35%153.09%-465.63%35.77%
Buyback Yield / Dilution
-17.86%-13.21%4.88%15.21%-16.87%0.52%
Total Shareholder Return
-17.86%-13.21%5.69%15.21%-15.78%1.31%
Source: S&P Global Market Intelligence. Standard template. Financial Sources.